Myoderm is granted a Wholesale Drug License to buy, sell and distribute
pharmaceuticals within England
Norristown, PA – March 7, 2011, Myoderm, a leading global supplier of commercial
drugs for clinical research and clinical trials, today announced that they have been
granted a Wholesale Dealer License from the Medicines and Healthcare products
Regulatory Agency (MHRA). In addition, Myoderm has established a new partnership
with a leading European Pharmaceutical logistics provider.
The license agreement granted by the MHRA enables Myoderm to buy, sell and
distribute pharmaceuticals within the UK. Providing more direct access to drug
manufacturers across Europe, the Wholesale Dealer License will facilitate Myoderm’s
current supply capabilities and business objectives of commercial expansion and strategic
positioning within the European Pharmaceutical Market.
“Acquiring our Wholesale Dealer License and partnering with a leading European,
Pharmaceutical logistics provider is critical to our continued effort to enhance our
worldwide supply capabilities,” says Mike Cohen, Myoderm’s Managing Director.
Along with the MHRA license agreement, Myoderm’s newest partnership will allow
them to offer receiving, inspection, warehousing and distribution of pharmaceutical
products. These services will allow Myoderm to have complete control over materials
procured and distributed throughout Europe.
With a proven track record of supply and distribution of pharmaceuticals to depots,
clinical trial sites, sponsor companies and clinical packagers around the globe, Myoderm
has evolved into a leader within the Clinical Trial Drug Supply industry for over 20
years. Myoderm is confident in its capabilities to continue to expand and strengthen its
international relationships. For more information on Myoderm, contact Lorann Morse at
+1.610.233.3304 or firstname.lastname@example.org.